Lingming Liang

570 total citations
14 papers, 347 citations indexed

About

Lingming Liang is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Nutrition and Dietetics. According to data from OpenAlex, Lingming Liang has authored 14 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrine and Autonomic Systems and 5 papers in Nutrition and Dietetics. Recurrent topics in Lingming Liang's work include Regulation of Appetite and Obesity (6 papers), Biochemical Analysis and Sensing Techniques (5 papers) and Immunotherapy and Immune Responses (2 papers). Lingming Liang is often cited by papers focused on Regulation of Appetite and Obesity (6 papers), Biochemical Analysis and Sensing Techniques (5 papers) and Immunotherapy and Immune Responses (2 papers). Lingming Liang collaborates with scholars based in United States, China and Germany. Lingming Liang's co-authors include Kang Dai, Jinlong Chen, Wanbo Li, Hui Tian, Shu‐Gui Huang, Gene Cutler, Juan Du, Jack Zhao, Songzhu An and Juan C. Jaén and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Lingming Liang

14 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingming Liang United States	10	168	132	122	42	39	14	347
Lars Dan Johansen Denmark	8	67 0.4×	245 1.9×	114 0.9×	39 0.9×	34 0.9×	8	416
Alma L. Burlingame United States	5	102 0.6×	306 2.3×	17 0.1×	60 1.4×	37 0.9×	7	436
Alicia González-González Spain	11	165 1.0×	122 0.9×	11 0.1×	53 1.3×	49 1.3×	14	334
Aditya J. Desai United States	11	47 0.3×	168 1.3×	16 0.1×	31 0.7×	27 0.7×	16	346
Young Jae Bahn South Korea	11	30 0.2×	247 1.9×	17 0.1×	95 2.3×	17 0.4×	14	379
Wen-Ji Chen United States	8	65 0.4×	248 1.9×	52 0.4×	21 0.5×	47 1.2×	8	360
Xiahui Tan Australia	11	14 0.1×	169 1.3×	51 0.4×	110 2.6×	25 0.6×	13	361
Natacha Moulharat France	10	54 0.3×	313 2.4×	7 0.1×	43 1.0×	25 0.6×	11	444
Makoto Asaumi Japan	7	95 0.6×	226 1.7×	39 0.3×	137 3.3×	33 0.8×	7	388

Countries citing papers authored by Lingming Liang

Since Specialization

Citations

This map shows the geographic impact of Lingming Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingming Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingming Liang more than expected).

Fields of papers citing papers by Lingming Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingming Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingming Liang. The network helps show where Lingming Liang may publish in the future.

Co-authorship network of co-authors of Lingming Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingming Liang. A scholar is included among the top collaborators of Lingming Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingming Liang. Lingming Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Eng, Jason S., Lingming Liang, Cong Li, et al.. (2022). Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway. Journal for ImmunoTherapy of Cancer. 10(3). e004348–e004348. 26 indexed citations

Jian, Chengfeng, et al.. (2021). An improved memory networks based product model classification method. International Journal of Computer Integrated Manufacturing. 34(3). 293–306. 3 indexed citations

Li, Cong, Madeline Fort, Lingming Liang, et al.. (2020). 718 AMG 509, a STEAP1 x CD3 bispecific XmAb^® 2+1 immune therapy, exhibits avidity-driven binding and preferential killing of high STEAP1-expressing prostate and Ewing sarcoma cancer cells. SHILAP Revista de lepidopterología. A430.1–A430. 2 indexed citations

Li, Cong, Liqin Liu, Lingming Liang, et al.. (2014). AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 14(2). 375–383. 27 indexed citations

Motani, Alykhan, Jian Luo, Lingming Liang, et al.. (2013). Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity models. Pharmacology Research & Perspectives. 1(1). e00003–e00003. 9 indexed citations

Kim, Yong‐Jae, Mike E. Lizarzaburu, Xiaoqi Chen, et al.. (2012). Discovery of a new class of ghrelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(5). 2046–2051. 15 indexed citations

Dai, Kang, Cong Li, Lingming Liang, et al.. (2012). Abstract LB-249: Characterization of a novel potent and selective CDK4/6 inhibitor and a resistance mechanism. Cancer Research. 72(8_Supplement). LB–249. 1 indexed citations

Fan, Pingchen, Xiaoqi Chen, Xi Chen, et al.. (2012). Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition. Bioorganic & Medicinal Chemistry Letters. 22(11). 3781–3785. 14 indexed citations

Lo, Mei-Chu, Kang Dai, Cong Li, et al.. (2011). Development of a time-resolved fluorescence resonance energy transfer assay for cyclin-dependent kinase 4 and identification of its ATP-noncompetitive inhibitors. Analytical Biochemistry. 421(2). 368–377. 5 indexed citations

10.

Chen, Xiaoqi, Pingchen Fan, Ying Fu, et al.. (2011). Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 21(23). 7001–7005. 15 indexed citations

11.

Chen, Xiaoqi, Jeff Mihalic, Pingchen Fan, et al.. (2011). Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2. Bioorganic & Medicinal Chemistry Letters. 22(1). 363–366. 15 indexed citations

12.

Yu, Ming, Mike E. Lizarzaburu, Holger Beckmann, et al.. (2010). Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 20(5). 1758–1762. 18 indexed citations

13.

Beck, Hilary P., Todd J. Kohn, Steven M. Rubenstein, et al.. (2007). Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 18(3). 1037–1041. 36 indexed citations

14.

An, Songzhu, Gene Cutler, Jack Zhao, et al.. (2001). Identification and characterization of a melanin-concentrating hormone receptor. Proceedings of the National Academy of Sciences. 98(13). 7576–7581. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact